Files in This Item:


Title: Measuring transparency to improve good governance in the public pharmaceutical sector: Oman
Authors: World Health Organization, Regional Office for the Eastern Mediterranean
Issue Date: 2016
Publisher: World Health Organization. Regional Office for the Eastern Mediterranean
Place of publication: Cairo
Language: English
Abstract: This report presents the findings of the first phase of the national Good Governance for Medicines programme. In recent years, countries of the WHO Eastern Mediterranean Region have made significant achievements in the provision of health services. In the pharmaceutical field, countries have been striving to improve the structures and regulations pertaining to medicines and have progressed in many ways. However, there are still important challenges. The goal of the WHO Good Governance for Medicines programme is to improve the situation of medicines regulation and supply. National transparency assessment is the beginning of a process aimed at bringing about desirable and sustainable changes in the governance of the pharmaceutical sector
Description: 86 p.
Subject: Drug Approval
Pharmaceutical Services
Public Sector
Drug Evaluation
Government Regulation
Context: organization and administration
ISBN: 978-92-9022-128-9
Other Identifiers: 978-92-9022-129-6 (Online)
Appears in Collections:EMRO Publications

Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.